Expression, regulation and function of autotaxin in thyroid carcinomas

International Journal of Cancer

Volumn 109, Issue 6, 2004, Pages 833-838

  Kehlen, Astrid ^a   Englert, Nadine ^a   Seifert, Anja ^a   Klonisch, Thomas ^a   Dralle, Henning ^a   Langner, Jürgen ^a   Hoang Vu, Cuong ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Autotaxin; Lysophospholipase D; Motility; Thyroid carcinoma

Indexed keywords

AUTOTAXIN; BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE D; MESSENGER RNA; NUCLEOTIDE PYROPHOSPHATASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKER; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GOITER; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; AGED, 80 AND OVER; AUTOCRINE MOTILITY FACTOR; CARCINOMA; CARCINOMA, PAPILLARY; EPIDERMAL GROWTH FACTOR; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GOITER; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-4; INTERLEUKIN-8; MALE; MIDDLE AGED; MULTIENZYME COMPLEXES; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 6044257511     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20022     Document Type: Article

References (40)

1. Stracke M, Liotta LA, Schiffmann E. The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility. Symp Soc Exp Biol 1993;47:197-214.
2. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, and Liotta LA. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992;267:2524-9.
3. Stracke ML, Clair T, Liotta LA. Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 1997;37:135-44.
4. Stassar MJ, Devitt G, Brosius M, Rinnab L, Prang J, Schradin T, Simon J, Petersen S, Kopp-Schneider A, and Zollar M. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization. Br J Cancer 2001;85:1372-82.
5. Murata J, Lee HY, Clair T, Krutzsch HC, Arestad AA, Sobel ME, Liotta LA, and Stracke ML. cDNA cloning of the human tumor motility-stimulating protein, autotaxin, reveals a homology with phosphodiesterases. J Biol Chem 1994;30479-84.
6. Zimmermann H, Braun N. Ecto-nucleotidases-molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res 1999;120:371-85.
7. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, and Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 2002;158:227-33.
8. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, and Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 2002;277:39436-42.
9. Koh E, Clair T, Woodhouse EC, Schiffmann E, Liotta L, Stracke M. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities. Cancer Res 2003;63:2042-5.
10. Gijsbers R, Aoki J, Arai H, Bollen M. The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site. FEBS Lett 2003;538:60-4.
11. Zhang G, Zhao Z, Xu S, Ni L, Wang X. Expression of autotaxin mRNA in human hepatocellular carcinoma. Chin Med J (Engl) 1999;112:330-2.
12. Yang Y, Mou L, Liu N, Tsao MS. Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol 1999;21:216-22.
13. Yang SY, Lee J, Park CG, Kim S, Hong S, Chung HC, Min SK, Han JW, Lee HW, and Lee HY. Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis 2002;19:603-8.
14. Kawagoe H, Stracke ML, Nakamura H, Sano K. Expression and transcriptional regulation of the PD-1alpha/autotaxin gene in neuroblastoma. Cancer Res 1997;57:2516-21.
15. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML. Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 2000;19:241-7.
16. Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA, and Stracke ML. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 2001;61:6938-44.
17. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
18. Hoelting T, Zielke A, Siperstein AE, Clark OH, Duh QY. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro. Clin Exp Metastasis 1994;12:315-23.
19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
20. Kehlen A, Thiele K, Riemann D, Langner J. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol 2002;127:539-46.
21. Imamura S, Horiuti Y. Enzymatic determination of phospholipase D activity with choline oxidase. J Biochem (Tokyo) 1978;83:677-80.
22. Koh E, Clair T, Woodhouse EC, Schiffmann E, Liotta L, Stracke M. Site-directed Mutations in the Tumor-associated Cytokine, Autotaxin, eliminate nucleotide Phosphodiesterase, Lysophospholipase D, and motogenic activities. Cancer Res 2003;63:2042-5.
23. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.
24. Kehlen A, Lauterbach R, Santos AN, Thiele K, Kabisch U, Weber E, Riemann D, and Langner J. IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol 2001;123:147-54.
25. Hoelting T, Zielke A, Siperstein AE, Clark OH, Duh QY. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro. Clin Exp Metastasis 1994;12:315-23.
26. Hoelting T, Siperstein AE, Clark OH, Duh QY. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. J Clin Endocrinol Metab 1994;79:401-8.
27. Duh QY, Clark OH. Factors influencing the growth of normal and neoplastic thyroid tissue. Surg Clin North Am 1987;67:281-98.
28. Westermark K, Westermark B, Karlsson FA, Ericson LE. Location of epidermal growth factor receptors on porcine thyroid follicle cells and receptor regulation by thyrotropin. Endocrinology 1986;118:1040-6.
29. Eggo MC, Hopkins JM, Franklyn JA, Johnson GD, Sanders DS, Sheppard MC. Expression of fibroblast growth factors in thyroid cancer. J Clin Endocrinol Metab 1995;80:1006-11.
30. Shingu K, Sugenoya A, Itoh N, Kato R. Expression of basic fibroblast growth factor in thyroid disorders. World J Surg 1994;18:500-5.
31. Thompson SD, Franklyn JA, Watkinson JC, Verhaeg JM, Sheppard MC, Eggo MC. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia. J Clin Endocrinol Metab 1998;83:1336-41.
32. Hu YL, Tee MK, Goetzl EJ, Auersperg N, Mills GB, Ferrara N, and Jaffe RB. Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J Natl Cancer Inst 2001;93:762-8.
33. Shida D, Kitayama J, Yamaguchi H, Okaji Y, Tsuno NH, Watanabe T, Takuwa Y, and Nagawa H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003;63:1706-11.
34. Schwartz BM, Hong G, Morrison BH, Wu W, Baudhuin LM, Xiao YJ, Mok SC, and Xu Y. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells. Gynecol Oncol 2001;81:291-300.
35. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci U S A 1989;86:641-4.
36. Tempia-Caliera AA, Horvath LZ, Zimmermann A, Tihanyi TT, Korc M, Friess H, and Buchler MW. Adhesion molecules in human pancreatic cancer. J Surg Oncol 2002;79:93-100.
37. Koyama S, Ebihara T, Fukao K. Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol 1992;118:609-14.
38. Arnold JM, Cummings M, Purdie D, Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 2001;85:1351-8.
39. Maeda K, Kang SM, Sawada T, Nishiguchi Y, Yashiro M, Ogawa Y, Ohira M, Ishikawa T, and Hirakawa-YS CK. Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer. Oncol Rep 2002;9:511-4.
40. Tanaka H, Yashiro M, Sunami T, Ohira M, Hirakawa Y. Lipid-mediated gene transfection of intercellular adhesion molecule-1 suppresses the peritoneal metastasis of gastric carcinoma. Int J Mol Med 2002;10:613-7.